Vacuolated Monocytes on Peripheral Blood Smear
Cytoplasmic vacuolation in peripheral blood monocytes is a morphological finding that requires systematic evaluation to distinguish between benign reactive processes (most commonly infections or storage disorders) and malignant conditions, particularly chronic myelomonocytic leukemia (CMML) when accompanied by persistent monocytosis >1×10⁹/L.
Clinical Significance
Vacuolated monocytes represent activated or dysfunctional cells and can indicate:
Reactive/Benign Causes
- Infectious processes - Most common cause, particularly bacterial sepsis (including Salmonella species 1) and parasitic infections like Chagas' disease 2
- Storage disorders - Lysosomal storage diseases
- Toxic exposures - Alcohol, certain medications
- Metabolic disturbances
Malignant/Clonal Causes
- Chronic myelomonocytic leukemia (CMML) - When vacuolation occurs with persistent monocytosis
- Acute myeloid leukemia (AML) with monocytic differentiation
- Other myelodysplastic/myeloproliferative neoplasms
Diagnostic Evaluation Algorithm
Step 1: Quantify Monocytosis
- Count absolute monocyte count (AMC) from the complete blood count
- Persistent monocytosis >1×10⁹/L for ≥3 months raises concern for CMML 3
- Document WBC count (cutoff of 13×10⁹/L distinguishes dysplastic vs proliferative variants) 3
Step 2: Exclude Reactive Causes
Obtain detailed history focusing on:
- Recent or current infections (bacterial, viral, parasitic)
- Solid tumor history (paraneoplastic monocytosis)
- Inflammatory conditions
- Medication exposures
Physical examination must assess:
- Splenomegaly (palpable spleen suggests clonal process)
- Cutaneous lesions (can occur in CMML)
- Signs of infection or inflammation 3
Step 3: Peripheral Smear Review
Critical morphological features to document:
- Percentage of vacuolated monocytes
- Presence of dysgranulopoiesis (hypogranular or hypolobated neutrophils)
- Presence of promonocytes, blasts, or immature myeloid cells
- Blast percentage (<5% in peripheral blood for CMML) 3
Step 4: If Monocytosis Persists or Dysplasia Present
Mandatory workup includes:
Bone marrow aspiration and biopsy 3, 4
- Assess dysplasia in erythroid, granulocytic, megakaryocytic lineages
- Blast count (must include myeloblasts, monoblasts, promonocytes; <20% for CMML)
- Prussian blue stain for ringed sideroblasts
- Marrow cellularity assessment
Bone marrow biopsy staining 3
- Hematoxylin-eosin
- CD34+ immunostaining
- CD68R and CD163 for monocytic cells
- Gomori's silver for fibrosis
- Reticulin stain for fibrosis 4
Conventional cytogenetic analysis 3, 4
- Detect clonal abnormalities (chromosome 7 abnormalities, trisomy 8, complex karyotype common in CMML)
- Must exclude t(9;22) and Philadelphia chromosome
Molecular assays 3
- BCR-ABL1 fusion gene (exclude chronic myeloid leukemia)
- PDGFRA and PDGFRB rearrangements if eosinophilia present (exclude MDS/MPN with eosinophilia)
- Monocytic aberrancies: abnormal CD11b/HLA-DR, CD36/CD14, altered CD13/CD14/CD16/CD33 intensity
- CD34+ blast enumeration (for reference only; use morphologic blast count for prognosis)
- Screen for PNH clone
- Assess for large granular lymphocytic disease
Additional useful studies:
WHO 2008 Diagnostic Criteria for CMML
All five criteria must be met 3:
- Persistent peripheral blood monocytosis >1×10⁹/L
- No Philadelphia chromosome or BCR-ABL1 fusion gene
- No PDGFRA or PDGFRB rearrangement
- <20% blasts in peripheral blood and bone marrow
- At least one of:
- Dysplasia in ≥1 cell lineage, OR
- Acquired clonal cytogenetic/molecular abnormality, OR
- Monocytosis persisting ≥3 months with no other identifiable cause
Critical Pitfalls to Avoid
- Do not rely on flow cytometry blast percentage for diagnosis - morphologic assessment by experienced hematopathologist is required for accurate blast enumeration and prognostic stratification 4
- Do not assume infection is excluded without thorough investigation - reactive monocytosis with vacuolation is far more common than CMML
- Do not delay bone marrow evaluation if monocytosis persists >3 months or any dysplasia is present on peripheral smear
- Promonocytes must be counted as blasts when calculating blast percentage in CMML 3
- Insufficient blood tube filling can alter monocyte percentages - ensure proper sample collection 5
When to Refer to Hematology
Immediate referral if:
- Persistent monocytosis >1×10⁹/L for >3 months
- Any dysplastic features on peripheral smear
- Splenomegaly with monocytosis
- Blasts or promonocytes identified
- Unexplained cytopenias accompanying monocytosis
Observation acceptable if:
- Acute infection identified with appropriate clinical context
- Monocytosis resolves with treatment of underlying condition
- No dysplasia, normal spleen size, no cytopenias
- Follow-up CBC in 1-3 months shows resolution